Classification Committee

Name	Company
Theresa Ormiston (Managing Chair)	IQVIA - UK
Anthony Palkovic (Co-Chair PBIRG)	Pfizer - USA
Gregory Senac (Co-Chair EphMRA)	Pierre-Fabre Medicament - France
Marilena Lauriola	MSD - Italy
Nicola Friend	AstraZeneca - UK
Mokhtar Diallo	Sanofi - France
Rainer Deuter	Norgine - Germany
Philip Reynolds	IQVIA - UK
James Street	Specialist Adviser - USA
Yuichi Eto	Takeda, Japan - Special Japanese Liaison Associate
Martin Molthagen	Lilly - Germany
Joao Saraiva	Astellas - UK
Monika Vogelmann	Daiichi Sankyo - Germany

Developing and improving the Anatomical Classification system in line with changes in pharmaceutical markets
Providing information to ensure the correct classification of products in secondary data supplier services
Responding to requests on classification issues from users of the system
Liaising with the WHO to ensure that the two classification systems converge rather than diverge
Communicating changes to PBIRG (minutes, exchange of information, etc.)
Conducting a survey of EphMRA & PBIRG on proposed changes to the classification system
Reconciliation of differences of opinions in the classification of products.

NEW! Apprentice Opportunity on Classification Committee (for pharma members) - read on. Please use the Application Form.

Comparison of the WHO ATC Classification 2016 - uploaded April 2016

Who we are, What we Do - 2016 Booklet.

Click here for a slide deck overview (Jan 2017).

ATC 2016